Effectiveness Analysis of Percutaneous Kyphoplasty Combined with Zoledronic Acid in Treatment of Primary Osteoporotic Vertebral Compression Fractures

被引:5
|
作者
Huang, Zi-Feng [1 ]
Xiao, Shao-Xiong [1 ]
Liu, Kun [1 ]
Xiong, Wei [1 ]
机构
[1] Wuhan 1 Hosp, Dept Spine Surg, 215 Zhongshan Rd, Wuhan 430000, Hubei, Peoples R China
关键词
Kyphoplasty; zoledronic acid; primary osteoporotic vertebral compression fractures; RISK-FACTORS; VERTEBROPLASTY; INFUSION;
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective: To investigate the therapeutic effectiveness of percutaneous kyphoplasty (PKP) combined with zoledronic acid in treatment of primary osteoporotic vertebral compression fractures. Study Design: A perspective cohort study was conducted at a single institution for patients, who received PKP operation due to primary osteoporotic vertebral compression fracture between January 2014 and January 2015. Setting: According to whether they received postoperative zoledronic acid or not, patients were divided into treatment or control groups, with 30 randomly-selected cases per group. Methods: The visual analogue scale (VAS), which was used to assess the degree of pain, and the bone mineral density, was analyzed at 1-, 6-, and 12-month follow-ups. Results: In general, patients experienced marked pain relief after surgery. No significant difference in pain relief was observed in the control group between the 6 and 12-month follow-up. In contrast, the VAS score of the treatment group at 12-month follow-up was significantly lower than that at 6-month (P value = 0.03). Moreover, it was also significantly lower than the VAS score in the control group at the 12-month follow-up (P value = 0.0018). The bone mineral density of patients from the treatment group increased significantly and progressively after the surgery (pre-operation versus 6-month follow-up: P value = 0.01; 6-month versus 12-month follow-up: P value < 0.001), and it was also remarkably higher than that of the control group at the 12-month follow-up (P value < 0.0001). Limitations: Patients were collected from a single hospital. The maximum postoperative follow-up time was 12 months. The sample size was relatively small. Thus, bias could occur in the selection of cases if they are not representative of the population. Conclusion: The combined treatment of zoledronic acid with PKP for primary osteoporotic vertebral compression fractures safely and effectively relieved low back pain, significantly increased bone density, and improved the quality of life. The clinical effectiveness is promising and worthy of further study.
引用
收藏
页码:63 / 68
页数:6
相关论文
共 50 条
  • [1] Re: "Effectiveness Analysis of Percutaneous Kyphoplasty Combined with Zoledronic Acid in Treatment of Primary Osteoporotic Vertebral Compression Fractures"
    Aminnejad, Reza
    PAIN PHYSICIAN, 2020, 23 (01) : E68 - E68
  • [2] Effectiveness and safety of percutaneous kyphoplasty combined with zoledronic acid in treatment of osteoporotic vertebral compression fractures: a meta-analysis
    Min Zhuang
    Bin Cai
    Fanfan Wang
    Archives of Orthopaedic and Trauma Surgery, 2022, 142 : 2435 - 2443
  • [3] Effectiveness and safety of percutaneous kyphoplasty combined with zoledronic acid in treatment of osteoporotic vertebral compression fractures: a meta-analysis
    Zhuang, Min
    Cai, Bin
    Wang, Fanfan
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2022, 142 (10) : 2435 - 2443
  • [4] Clinical Efficacy Analysis of Percutaneous Kyphoplasty Combined with Zoledronic Acid in the Treatment and Prevention of Osteoporotic Vertebral Compression Fractures
    Liu, Bin
    Gan, Fusheng
    Ge, Yu
    Yu, Haiyang
    JOURNAL OF INVESTIGATIVE SURGERY, 2018, 31 (05) : 425 - 430
  • [5] The Effect of Zoledronic Acid Combined with Percutaneous Kyphoplasty on the Treatment of Osteoporotic Vertebral Body Compression Fractures in Patients
    Zheng, Huayong
    Li, Haipeng
    Zhang, Jianzheng
    Ren, Jixin
    Li, Shaoguang
    Liu, Zhi
    Sun, Tiansheng
    JOURNAL OF BIOMATERIALS AND TISSUE ENGINEERING, 2019, 9 (07) : 1008 - 1013
  • [6] Percutaneous kyphoplasty combined with zoledronic acid for the treatment of primary osteoporotic vertebral compression fracture: a prospective, multicenter study
    Kan Liu
    Guanzhong Tan
    Wei Sun
    Qiang Lu
    Jiaguang Tang
    Dong Yu
    Archives of Orthopaedic and Trauma Surgery, 2023, 143 : 3699 - 3706
  • [7] Percutaneous kyphoplasty combined with zoledronic acid for the treatment of primary osteoporotic vertebral compression fracture: a prospective, multicenter study
    Liu, Kan
    Tan, Guanzhong
    Sun, Wei
    Lu, Qiang
    Tang, Jiaguang
    Yu, Dong
    ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2023, 143 (07) : 3699 - 3706
  • [8] Zoledronic Acid in Osteoporotic Vertebral Compression Fractures Treated With Percutaneous Kyphoplasty: A Meta-Analysis
    Tian, Peng
    Liu, Yue
    Li, Zhi-jun
    Xu, Gui-jun
    Ma, Xin-long
    FRONTIERS IN SURGERY, 2021, 8
  • [9] Efficacy of zoledronic acid with percutaneous kyphoplasty/vertebroplasty in the treatment of osteoporotic vertebral compression fractures: a systematic review and meta-analysis
    Wu, X-G
    Zhang, D-Y
    Zhu, B-Q
    Li, A-M
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (23) : 12358 - 12367
  • [10] Percutaneous kyphoplasty combined with zoledronic acid infusion in the treatment of osteoporotic thoracolumbar fractures in the elderly
    Shi, Chen
    Zhang, Mi
    Cheng, An-Yuan
    Huang, Zi-Feng
    CLINICAL INTERVENTIONS IN AGING, 2018, 13 : 853 - 861